Fig. 4From: Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stainsClots from three type 2 diabetes individuals with added amyloid–specific fluorescent markers (rows a to c represent 3 different individuals with type 2 diabetes); columns from left to right Amytracker 680 (red), Amytracker 480 (blue) and ThT (green)Back to article page